A cholesteryl ester transfer protein inhibitor attenuate atherosclerosis in rabbits

Nature

Volumn 406, Issue 6792, 2000, Pages 203-207

  Okamoto, Hiroshi ^a   Yonemori, Fumihiko ^a   Wakitani, Korekiyo ^a   Minowa, Takashi ^b   Maeda, Kimiya ^a   Shinkai, Hisashi ^a  

^a JT Inc   (Japan)

^b JT Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLPROPANETHIOIC ACID S [2 [1 (2 ETHYLBUTYL)CYCLOHEXYLCARBOXAMIDO]PHENYL] ESTER; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; LOW DENSITY LIPOPROTEIN; PROTEIN INHIBITOR; SIMVASTATIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DISULFIDE BOND; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ARTERIOSCLEROSIS; CARRIER PROTEINS; CELL LINE; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL ESTERS; CHOLESTEROL, HDL; DISULFIDES; GLYCOPROTEINS; HUMANS; MALE; RABBITS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFHYDRYL COMPOUNDS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0034644214     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35018119     Document Type: Article

References (28)

1. Tall, A. R. Plasma cholesterol ester transfer protein. J. Lipid Res. 34, 1255-1274 (1993).
2. Lagrost, L. Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies. Biochem. Biophys. Acta. 1215, 209-236 (1994).
3. Brown, M. L. et al. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 342, 448-451 (1989).
4. Marotti, K. R. et al. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 364, 73-75 (1993).
5. Quinet, E., Tall, A. R., Ramakrishnan, R. & Rudel, L. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J. Clin. Invest. 87, 1559-1566 (1991).
6. Bhatnagar, D. et al. Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease. Atherosclerosis 98, 25-32 (1993).
7. Foger, B., Luef, G. & Ritsch, A. Relationship of high-density lipoprotein subfractions and cholesteryl ester transfer protein in plasma to carotid artery wall thickness. J. Mol. Med. 73, 369-372 (1995).
8. Sugano, M. et al. Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits. J. Biol. Chem. 273, 5033-5036 (1998).
9. Herrera, V. L., et al. Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesleryl ester transfer protein. Nature Med. 5, 1383-1389 (1999).
10. Bruce, C., Chouinard, R. A. Jr & Tall, A. R. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu. Rev. Nutr. 18, 297-330 (1998).
11. Fielding, C. J. & Havel, R. J. Cholesteryl ester transfer proteins: friend or foe? J. Clin. Invest. 97, 2687-2688 (1996).
12. Hayek, T., Masucci-Magoulas, L. & Jiang, X. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J. Clin. Invest. 96, 2071-2074 (1995).
13. Zhong, S. et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J. Clin. Invest. 97, 2917-2923 (1996).
14. Foger, B. et al. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice. J. Biol. Chem. 274, 36912-36920 (1999).
15. Fielding, C. J. & Fielding, P. E. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36, 211-228 (1995).
16. Connolly, D. T., Heuvelman, D. & Glenn, K. Inactivation of cholesteryl ester transfer protein by cysteine modification. Biochem. Biophys. Res. Commun. 225, 42-47 (1996).
17. Morton, R. E. & Zilversmit, D. B. Inter-relationship of lipid transferred by the lipid-transfer protein isolated from human lipoprotein-deficient plasma. J. Biol. Chem. 258, 11751-11757 (1983).
18. Frank, D. et al. Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol: methodological considerations regarding individual variability in response to dietary cholesterol and development of lesion type. Artherioscler. Thromb. Vasc. Biol. 16, 1454-1464 (1996).
19. Whitlock, M. E. et al. Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit. Effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism. J. Clin. Invest. 84, 129-137 (1989).
20. Inazu, A. et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N. Engl. J. Med. 323, 1234-1238 (1990).
21. Wilson, P. W. F., Abbot, R. D. & Castelli, W. P. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis. 8, 737-741 (1988).
22. Oram, J. F. & Yokoyama, S. Apoprotein-mediated removal of cellular cholesterol and phospholipids. J. Lipid. Res. 37, 2473-2491 (1996).
23. Mackness, M. I. & Durrington, P. N. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis. 115, 243-253 (1995).
24. Suc, I., Escargueil-Blanc, I., Troy, M., Salvayre, R. & Negre-Salvayre, A. HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL. Arterioscler. Thromb. Vasc. Biol. 17, 2158-2166 (1997).
25. Kunkel, T. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl Acad. Sci. USA 82, 488-492 (1985).
26. Tollefson, J. H. & Albers, J. J. Isolation, characterization, and assay of plasma lipid transfer protein. Methods Enzymol. 129, 797-816 (1986).
27. Chiba, H. et al. Quantitative and compositional changes in high density lipoprotein subclasses in patients with various genotypes of cholesteryl ester transfer protein deficiency. J. Lipid Res. 38, 1204-1216 (1997).
28. Gerdes, L. U., Gerdes, C., Klausen, I. C. & Faergeman, O. Generation of analytic plasma lipoprotein profiles using two prepacked Superose 6B columns. Clin. Clim. Acta 205, 1-9 (1992).